Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression-Reference-Cited by-同舟云学术

Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression

Published:2017-08 Issue:33 Volume:292 Page:13688-13701
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Roy Abhishek,Ansari Shabbir A.,Das Kaushik,Prasad Ramesh,Bhattacharya Anindita,Mallik Suman,Mukherjee Ashis,Sen Prosenjit^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference48 articles.

1. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?;Versteeg;Thromb. Haemost,2001

2. High affinity Ca2+-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity;Sabharwal;J. Biol. Chem,1995

3. Biochemistry and physiology of blood coagulation;Mann;Thromb. Haemost,1999

4. Structural modulation of factor VIIa by full-length tissue factor (TF1–263): implication of novel interactions between EGF2 domain and TF;Prasad;J. Biomol. Struct. Dyn,2017

5. Tissue factor as a novel target for treatment of breast cancer;Cole;Oncologist,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion;Journal of Thrombosis and Haemostasis;2023-12

2. CIP2A interacts with AKT1 to promote the malignant biological behaviors of oral squamous cell carcinoma by upregulating the GSK‑3β/β‑catenin pathway;Experimental and Therapeutic Medicine;2023-09-20

3. The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans;Cancers;2023-02-28

4. Matrix metalloproteinases as therapeutic targets in breast cancer;Frontiers in Oncology;2023-01-19

5. Elucidation of the signalling pathways for enhanced exosome release from Mycobacterium ‐infected macrophages and subsequent induction of differentiation;Immunology;2022-10-14